$$$$$$$~BIG OTC DD PICKS AND LOW FLOAT MOVERS$$$$$$$

[$Pistol Pete$]

$PMCB recent news/filings



## source: finance.yahoo.com

Thu, 30 Jul 2015 13:00:00 GMT ~ PharmaCyte Biotech's Improved Technology Attracting World Class Oncologists

[Marketwired] - PharmaCyte Biotech is a small international biotechnology firm, but you wouldn't know it by the company it keeps. How does PharmaCyte keep landing such world-renowned oncologists? Well, we think the answer ...

read full: http://finance.yahoo.com/news/pharmacyte-biotechs-improved-technology-attracting-130000873.html
*********************************************************

Wed, 29 Jul 2015 20:05:04 GMT ~ PHARMACYTE BIOTECH, INC. Files SEC form 10-K, Annual Report


read full: http://biz.yahoo.com/e/150729/pmcb10-k.html
*********************************************************

Fri, 24 Jul 2015 13:00:00 GMT ~ Celgene May Also Want to Take Notice of PharmaCyte Biotech

[Marketwired] - A recent deal between Celgene and Juno Therapeutics is just a microcosm of the mindset that may ultimately drive a similar deal between it -- or a competitor -- and PharmaCyte Biotech .Last month, Celgene ...

read full: http://finance.yahoo.com/news/celgene-may-want-notice-pharmacyte-130000447.html
*********************************************************

Thu, 23 Jul 2015 14:31:12 GMT ~ PharmaCyte Biotech Begins Second Follow-Up Study on Ascites

[at noodls] - SILVER SPRING, MD, July 23, 2015 (GLOBE NEWSWIRE) - PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using ...

read full: http://www.noodls.com/view/578F3DAC498C6E636B1538BFF4D66F2AB1DC0BD8
*********************************************************

Thu, 23 Jul 2015 13:20:00 GMT ~ PharmaCyte Biotech Begins Second Follow-Up Study on Ascites

[GlobeNewswire] - SILVER SPRING, Md., July 23, 2015-- PharmaCyte Biotech, Inc., a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation ...

read full: http://finance.yahoo.com/news/pharmacyte-biotech-begins-second-study-132000831.html
*********************************************************